{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:17:18Z","timestamp":1795036638190,"version":"4.10.2"},"reference-count":227,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human papillomavirus (HPV) is a DNA virus with oncogenic potential. Persistent infections with high-risk HPV genotypes can drive malignant transformation in multiple tissues, resulting in distinct HPV-associated cancers. This review provides an analysis of the tumor microenvironment (TME) in head and neck squamous cell carcinoma (HNSCC) and squamous cell carcinoma of uterine cervix (CESC). First, we briefly introduce the key aspects of HPV biology and the mechanisms of carcinogenesis. We focus on the composition and functional states of immune cells within tumor tissues, highlighting how specific immune cells influence disease progression and clinical outcomes. By linking immunological features to patient prognosis, we outline the similarities and differences between the TME of HNSCC and CESC. Additionally, this review summarizes the current standards of care and emerging therapeutic strategies for patients with HPV-associated tumors. Altogether, by providing recent advances in the understanding of the TME of HPV-associated tumors, this review highlights the potential of targeting immune components within the tumor microenvironment for therapeutic benefit.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1813400","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:36:07Z","timestamp":1777613767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy response"],"prefix":"10.3389","volume":"17","author":[{"given":"Kl\u00e1ra","family":"Pla\u010dkov\u00e1","sequence":"first","affiliation":[{"name":"Sotio Biotech a.s.","place":["Prague, Czechia"]},{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, First Faculty of Medicine, Charles University and University Hospital Motol and Homolka","place":["Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fialov\u00e1","sequence":"additional","affiliation":[{"name":"Sotio Biotech a.s.","place":["Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01431-8","article-title":"HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers","volume":"39","author":"Ren","year":"2020","journal-title":"Oncogene"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/v9080208","article-title":"Integration of human papillomavirus genomes in head and neck cancer: Is it time to consider a paradigm shift","volume":"9","author":"Morgan","year":"2017","journal-title":"Viruses"},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcv.2013.12.006","article-title":"Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer","volume":"59","author":"Gao","year":"2014","journal-title":"J Clin Virol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41525-021-00264-y","article-title":"Recurrent integration of human papillomavirus genomes at transcriptional regulatory hubs","volume":"6","author":"Warburton","year":"2021","journal-title":"NPJ Genom Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.03.015","article-title":"Patients with integrated HPV16 in head and neck cancer show poor survival","volume":"80","author":"Nulton","year":"2018","journal-title":"Oral Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"20180289","DOI":"10.1098\/rstb.2018.0289","article-title":"Modelling human papillomavirus biology in oropharyngeal keratinocytes","volume":"374","author":"Roberts","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191581","article-title":"Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma","volume":"13","author":"Anayannis","year":"2018","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006721","article-title":"Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment","volume":"11","author":"McInnis","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1541-7786.mcr-17-0153","article-title":"HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers","volume":"16","author":"Koneva","year":"2018","journal-title":"Mol Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13051000","article-title":"Molecular insights into HPV-driven cervical cancer: Oncoproteins, immune evasion, and epigenetic modifications","volume":"13","author":"Pavelescu","year":"2025","journal-title":"Microorganisms"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29685","article-title":"High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects","volume":"96","author":"Lo Cigno","year":"2024","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00682","article-title":"Papillomavirus immune evasion strategies target the infected cell and the local immune system","volume":"9","author":"Zhou","year":"2019","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101884","DOI":"10.1016\/j.tranon.2024.101884","article-title":"Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix","volume":"41","author":"Pavelkova","year":"2024","journal-title":"Transl Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00795-021-00290-w","article-title":"Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy","volume":"54","author":"Someya","year":"2021","journal-title":"Med Mol Morphol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-1749","article-title":"The anatomical location shapes the immune infiltrate in tumors of same etiology and affects survival","volume":"25","author":"Santegoets","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038711","article-title":"Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer","volume":"7","author":"Nasman","year":"2012","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1498439","article-title":"Treatment-naive HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy","volume":"7","author":"Gameiro","year":"2018","journal-title":"Oncoimmunology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.965570","article-title":"Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma","volume":"4","author":"Partlova","year":"2015","journal-title":"Oncoimmunology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.211","article-title":"Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer","volume":"136","author":"Wansom","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s40425-019-0726-6","article-title":"Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8(+) T cells","volume":"7","author":"Hladikova","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br J Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.pathol.2017.02.002","article-title":"Prognostic markers in oropharyngeal squamous cell carcinoma: Focus on CD70 and tumour infiltrating lymphocytes","volume":"49","author":"De Meulenaere","year":"2017","journal-title":"Pathology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2016.04.004","article-title":"Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature","volume":"58","author":"Saber","year":"2016","journal-title":"Oral Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2018.02.005","article-title":"Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis","volume":"96","author":"Chen","year":"2018","journal-title":"Mol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.03.007","article-title":"A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer","volume":"68","author":"Bersani","year":"2017","journal-title":"Oral Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000452","article-title":"CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma","volume":"8","author":"Hewavisenti","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12885-025-13764-2","article-title":"Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: A systematic review and meta-analysis","volume":"25","author":"Ali","year":"2025","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26497","article-title":"Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer","volume":"131","author":"Heusinkveld","year":"2012","journal-title":"Int J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-2140","article-title":"Intratumoral HPV16-specific T cells constitute a type I-oriented tumor microenvironment to improve survival in HPV16-driven oropharyngeal cancer","volume":"24","author":"Welters","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/1538-7445.am2018-1002","article-title":"Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1","volume":"82","author":"Hladikova","year":"2018","journal-title":"Oral Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1371559","article-title":"Circulating T cells: A promising biomarker of anti-PD-(L)1 therapy","volume":"15","author":"Hou","year":"2024","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2022.07.004","article-title":"TCF1(+)PD-1(+) tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer","volume":"174","author":"Koh","year":"2022","journal-title":"Eur J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-022-00160-w","article-title":"A comprehensive profile of TCF1(+) progenitor and TCF1(-) terminally exhausted PD-1(+)CD8(+) T cells in head and neck squamous cell carcinoma: Implications for prognosis and immunotherapy","volume":"14","author":"Wang","year":"2022","journal-title":"Int J Oral Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1031643","article-title":"Identification of CD8+ T cell infiltration-related genes and their prognostic values in cervical cancer","volume":"12","author":"Shen","year":"2022","journal-title":"Front Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/medicina61112007","article-title":"Interplay between immune microenvironment CD8+ tumor-infiltrating lymphocytes and PDL-1 expression as prognostic markers in invasive cervical squamous cell carcinoma","volume":"61","author":"Petric\u0103","year":"2025","journal-title":"Medicina"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.07.106","article-title":"Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy","volume":"159","author":"Ohno","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1338230","article-title":"CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer","volume":"6","author":"Komdeur","year":"2017","journal-title":"Oncoimmunology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23162","article-title":"Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element","volume":"122","author":"Piersma","year":"2008","journal-title":"Int J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17223627","article-title":"T cell exhaustion in the cervical cancer tumor microenvironment: PD-1 overexpression and co-expression with TIGIT, Tim-3, LAG-3, and NKG2A","volume":"17","author":"Garcia-Barrientos","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: Differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","article-title":"Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms","volume":"28","author":"Tay","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.2007.00869.x","article-title":"Th2-mediated anti-tumour immunity: Friend or foe","volume":"70","author":"Ellyard","year":"2007","journal-title":"Tissue Antigens"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061650","article-title":"Role and potential of different T helper cell subsets in adoptive cell therapy","volume":"15","author":"Andreu-Sanz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.12.007","article-title":"T follicular helper cells in cancer","volume":"9","author":"Gutierrez-Melo","year":"2023","journal-title":"Trends Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3109\/00016489.2014.918279","article-title":"Regulatory T-cell infiltration in tongue squamous cell carcinoma","volume":"134","author":"Hanakawa","year":"2014","journal-title":"Acta Otolaryngol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109444","article-title":"The prognostic landscape of tumor-infiltrating immune cells in cervical cancer","volume":"120","author":"Wang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2019.1659094","article-title":"Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors","volume":"8","author":"Yang","year":"2019","journal-title":"Oncoimmunology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01701","article-title":"Immunological network in head and neck squamous cell carcinoma-a prognostic tool beyond HPV status","volume":"10","author":"Fialova","year":"2020","journal-title":"Front Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40425-019-0497-0","article-title":"Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses","volume":"7","author":"Santegoets","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/303929","article-title":"High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas","volume":"2014","author":"Lukesova","year":"2014","journal-title":"BioMed Res Int"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1442103","article-title":"The prognostic value of Th17\/Treg cell in cervical cancer: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cmi.2010.56","article-title":"A reversed CD4\/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix","volume":"8","author":"Shah","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.815449","article-title":"Optimized protocols for in-vitro T-cell-dependent and T-cell-independent activation for B-cell differentiation studies using limited cells","volume":"13","author":"Marsman","year":"2022","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s281-001-8167-7","article-title":"Naive and memory B cells in T-cell-dependent and T-independent responses","volume":"23","author":"Zubler","year":"2001","journal-title":"Springer Semin Immunopathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050449","article-title":"The B-side of cancer immunity: the underrated tune","volume":"8","author":"Largeot","year":"2019","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.ccr-12-3497","article-title":"Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma","volume":"19","author":"Shi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1900508","DOI":"10.1080\/2162402X.2021.1900508","article-title":"Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies","volume":"10","author":"N","year":"2021","journal-title":"Oncoimmunology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10788","article-title":"Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors","volume":"7","author":"Wood","year":"2016","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"Oncoimmunology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.21417\/atr2021nc","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-19-3211","article-title":"B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade","volume":"26","author":"Kim","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199034","article-title":"B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses","volume":"13","author":"Rossetti","year":"2018","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/2326-6066.cir-17-0075","article-title":"Antigen-presenting intratumoral B cells affect CD4(+) TIL phenotypes in non-small cell lung cancer patients","volume":"5","author":"Bruno","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2931-3","article-title":"Defining HPV-specific B cell responses in patients with head and neck cancer","volume":"597","author":"Wieland","year":"2021","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-3323","article-title":"HPV serum antibodies as predictors of survival and disease progression in patients with HPV-positive squamous cell carcinoma of the oropharynx","volume":"21","author":"Dahlstrom","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25015","article-title":"Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer","volume":"127","author":"Smith","year":"2010","journal-title":"Int J Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-12-3450","article-title":"Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijom.2017.02.481","article-title":"CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells","volume":"53","author":"Zhou","year":"2016","journal-title":"Oral Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1233085","article-title":"Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma","volume":"14","author":"Bao","year":"2023","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6519427","article-title":"Role of regulatory B cells in the progression of cervical cancer","volume":"2019","author":"Chen","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694079","article-title":"The 12-CK score: global measurement of tertiary lymphoid structures","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693234","article-title":"Prognostic significance of gene signature of tertiary lymphoid structures in patients with lung adenocarcinoma","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03310-5","article-title":"Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012613","article-title":"High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer","volume":"13","author":"Syding","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101949","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma","volume":"44","author":"Zhu","year":"2024","journal-title":"Transl Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1724763","article-title":"Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer","volume":"9","author":"Yamaguchi","year":"2020","journal-title":"Oncoimmunology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139905","article-title":"Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity","volume":"131","author":"Noel","year":"2021","journal-title":"J Clin Invest"},{"key":"B87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-020-00092-3","article-title":"Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma","volume":"12","author":"Li","year":"2020","journal-title":"Int J Oral Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101949","article-title":"Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8(+) T cells","volume":"17","author":"Wang","year":"2023","journal-title":"Mol Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2025.2466308","article-title":"Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma","volume":"14","author":"Ruiz-Torres","year":"2025","journal-title":"Oncoimmunology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5ma0322-746r","article-title":"Relationship and prognostic significance of IL-33, PD-1\/PD-L1, and tertiary lymphoid structures in cervical cancer","volume":"112","author":"Zhang","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205733","article-title":"Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma","volume":"16","author":"Xiong","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"21530","DOI":"10.1038\/s41598-020-78560-3","article-title":"Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-35723-8_1","article-title":"Neutrophils in the tumor microenvironment","volume":"1224","author":"Wu","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-0154-9_1","article-title":"The role of neutrophils in the immune system: an overview","volume":"1124","author":"Malech","year":"2014","journal-title":"Methods Mol Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/biom14020205","article-title":"Neutrophils in HNSCC can be associated with both a worse or favorable prognosis","volume":"14","author":"Brunkhorst","year":"2024","journal-title":"Biomolecules"},{"key":"B98","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-024-02004-z","article-title":"Neutrophils in cancer immunotherapy: friends or foes","volume":"23","author":"Huang","year":"2024","journal-title":"Mol Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25075","article-title":"Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis","volume":"40","author":"Mascarella","year":"2018","journal-title":"Head Neck"},{"key":"B100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3760\/cma.j.issn.0253-3766.2017.01.006","article-title":"Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma","volume":"39","author":"Wu","year":"2017","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24159","article-title":"Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma","volume":"38","author":"Rachidi","year":"2016","journal-title":"Head Neck"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29100","article-title":"Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status","volume":"121","author":"Huang","year":"2015","journal-title":"Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123113","article-title":"The prognosis performance of a neutrophil- and lymphocyte-associated gene mutation score in a head and neck cancer cohort","volume":"11","author":"Yeh","year":"2023","journal-title":"Biomedicines"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.11.206","article-title":"Neutrophils infiltration and its correlation with human papillomavirus status in the oral squamous cell carcinoma","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1139809","article-title":"Effects of peripheral blood neutrophil\/lymphocyte ratio levels and their changes on the prognosis of patients with early cervical cancer","volume":"13","author":"Du","year":"2023","journal-title":"Front Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2939162","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) predict clinical outcome in patients with stage IIB cervical cancer","volume":"2021","author":"Li","year":"2021","journal-title":"J Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17060921","article-title":"Neutrophil\/lymphocyte ratio (NLR) as a predictive marker for p16 positivity and cervical cancer progression: Insights from the SCOPE study","volume":"17","author":"Toth","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09079-3","article-title":"Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils","volume":"7","author":"Alvarez","year":"2017","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101516","article-title":"G-CSF - A double edge sword in neutrophil mediated immunity","volume":"54","author":"Martin","year":"2021","journal-title":"Semin Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.07.231","article-title":"The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer","volume":"20","author":"Ji","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.009","article-title":"The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy","volume":"145","author":"Matsumoto","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.167","article-title":"Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer","volume":"108","author":"Carus","year":"2013","journal-title":"Br J Cancer"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.659445","article-title":"Stromal neutrophil extracellular trap density is an independent prognostic factor for cervical cancer recurrence","volume":"11","author":"Yan","year":"2021","journal-title":"Front Oncol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217288","article-title":"S100A7 orchestrates neutrophil chemotaxis and drives neutrophil extracellular traps (NETs) formation to facilitate lymph node metastasis in cervical cancer patients","volume":"605","author":"Ning","year":"2024","journal-title":"Cancer Lett"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2024.109289","article-title":"Modelling the continuum of macrophage phenotypes and their role in inflammation","volume":"377","author":"Almansour","year":"2024","journal-title":"Math Biosci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136654","article-title":"Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical cancer","volume":"10","author":"Petrillo","year":"2015","journal-title":"PloS One"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.7150\/jca.21444","article-title":"Clinical significance of CD163+ and CD68+ tumor-associated macrophages in high-risk HPV-related cervical cancer","volume":"8","author":"Chen","year":"2017","journal-title":"J Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-3199","article-title":"CXCL1 is critical for premetastatic niche formation and metastasis in colorectal cancer","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.10.009","article-title":"CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis","volume":"24","author":"Katoh","year":"2013","journal-title":"Cancer Cell"},{"key":"B120","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbcan.2019.01.005","article-title":"Potential roles and targeted therapy of the CXCLs\/CXCR2 axis in cancer and inflammatory diseases","volume":"1871","author":"Cheng","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02523-w","article-title":"Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma","volume":"69","author":"Dar","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.cir-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1158\/1078-0432.ccr-14-1711","article-title":"Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Weed","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-3726","article-title":"Clinical relevance and suppressive capacity of human myeloid-derived suppressor cell subsets","volume":"24","author":"Lang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/srep18217","article-title":"The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer","volume":"5","author":"Kawano","year":"2015","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051073","article-title":"Myeloid-derived suppressor cells as therapeutic targets in uterine cervical and endometrial cancers","volume":"10","author":"Mabuchi","year":"2021","journal-title":"Cells"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41467-020-15186-z","article-title":"Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological Malignancies","volume":"11","author":"Mabuchi","year":"2020","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015855107","article-title":"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes","volume":"107","author":"Kowanetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-2472","article-title":"The highly metastatic nature of uterine cervical\/endometrial cancer displaying tumor-related leukocytosis: Clinical and preclinical investigations","volume":"24","author":"Sasano","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26711","article-title":"Estrogen stimulates female cancer progression by inducing myeloid-derived suppressive cells: Investigations on pregnant and non-pregnant experimental models","volume":"10","author":"Kozasa","year":"2019","journal-title":"Oncotarget"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113104","article-title":"NK cell regulation in cervical cancer and strategies for immunotherapy","volume":"10","author":"Gutierrez-Hoya","year":"2021","journal-title":"Cells"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00699","article-title":"Human CD56(dim)CD16(dim) cells as an individualized natural killer cell subset","volume":"8","author":"Amand","year":"2017","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01825","article-title":"Natural killer cell-based immunotherapy in gynecologic Malignancy: A review","volume":"8","author":"Uppendahl","year":"2017","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.896228","article-title":"All about (NK cell-mediated) death in two acts and an unexpected encore: Initiation, execution and activation of adaptive immunity","volume":"13","author":"Ramirez-Labrada","year":"2022","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00683","article-title":"Patient\u2019s natural killer cells in the era of targeted therapies: Role for tumor killers","volume":"8","author":"Messaoudene","year":"2017","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171464","article-title":"Maintaining the balance: Regulation of NK cell activity","volume":"13","author":"Imsirovic","year":"2024","journal-title":"Cells"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-135194","article-title":"ILT2\/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse","volume":"24","author":"Favier","year":"2010","journal-title":"FASEB J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002899","article-title":"Deregulation of HLA-I in cancer and its central importance for immunotherapy","volume":"9","author":"Hazini","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00167","article-title":"NK cell-based immune checkpoint inhibition","volume":"11","author":"Khan","year":"2020","journal-title":"Front Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: Underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.61.1509","article-title":"Immunology and immunotherapy of head and neck cancer","volume":"33","author":"Ferris","year":"2015","journal-title":"J Clin Oncol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01242","article-title":"Prognostic significance of tumor-infiltrating natural killer cells in solid tumors: A systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31213","article-title":"Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)","volume":"142","author":"Stangl","year":"2018","journal-title":"Int J Cancer"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1747345","article-title":"The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis","volume":"9","author":"Bisheshar","year":"2020","journal-title":"Oncoimmunology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-24-1535","article-title":"Exploring a specific type of tissue-resident natural killer cell involved in the anti-tumor and immunotherapy response in human papillomavirus-positive head and neck squamous cell carcinoma using scRNA-seq","volume":"13","author":"Lin","year":"2024","journal-title":"Transl Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1018685","article-title":"Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC","volume":"13","author":"Chi","year":"2022","journal-title":"Front Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2605741","article-title":"Single-cell landscape of peripheral and tumor-infiltrating immune cells in HPV-negative HNSCC","volume":"15","author":"Galvani","year":"2026","journal-title":"OncoImmunology"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29962","article-title":"CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma","volume":"138","author":"Wagner","year":"2016","journal-title":"Int J Cancer"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.22809","article-title":"Effect of IL-18 on the expansion and phenotype of human natural killer cells: Application to cancer immunotherapy","volume":"14","author":"Senju","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-186","article-title":"Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions","volume":"9","author":"Garcia-Iglesias","year":"2009","journal-title":"BMC Cancer"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9182979","article-title":"Human papillomavirus type 16 disables the increased natural killer cells in early lesions of the cervix","volume":"2019","author":"Zhang","year":"2019","journal-title":"J Immunol Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-022-01264-9","article-title":"Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143545","article-title":"Plasmacytoid dendritic cells, a novel target in myeloid neoplasms","volume":"14","author":"Roussel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.09.002","article-title":"Antigen-presentation properties of plasmacytoid dendritic cells","volume":"29","author":"Villadangos","year":"2008","journal-title":"Immunity"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040617","article-title":"IFN-alpha-mediated differentiation of dendritic cells for cancer immunotherapy: advances and perspectives","volume":"8","author":"Lapenta","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/s41598-023-28625-w","article-title":"Immature and mature bone marrow-derived dendritic cells exhibit distinct intracellular mechanical properties","volume":"13","author":"Leblanc-Hotte","year":"2023","journal-title":"Sci Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1039\/c9ra00818g","article-title":"Properties of immature and mature dendritic cells: phenotype, morphology, phagocytosis, and migration","volume":"9","author":"Kim","year":"2019","journal-title":"RSC Adv"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061660","article-title":"Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand","volume":"204","author":"Ito","year":"2007","journal-title":"J Exp Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01325","article-title":"Costimulatory molecules and immune checkpoints are differentially expressed on different subsets of dendritic cells","volume":"10","author":"Carenza","year":"2019","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic cells and cytokines in human inflammatory and autoimmune diseases","volume":"19","author":"Blanco","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03215.x","article-title":"Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity","volume":"146","author":"Kim","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40425-018-0446-3","article-title":"Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients","volume":"6","author":"Truxova","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(01)80925-4","article-title":"The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer","volume":"8","author":"Inoshima","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10915","article-title":"Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas","volume":"104","author":"Iwamoto","year":"2003","journal-title":"Int J Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040702","article-title":"Dendritic cells are associated with prognosis and survival in breast cancer","volume":"11","author":"Szpor","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0286-3","article-title":"Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor","volume":"56","author":"Ladanyi","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03271-9","article-title":"Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma","volume":"72","author":"Laheurte","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1414298","article-title":"Type I conventional dendritic cells and CD8(+) T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients","volume":"15","author":"Kirchner","year":"2024","journal-title":"Front Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749190","article-title":"The role of plasmacytoid dendritic cells in cancers","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.04.003","article-title":"Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response","volume":"255","author":"O\u2019Donnell","year":"2007","journal-title":"Cancer Lett"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02874-y","article-title":"The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC","volume":"70","author":"Koucky","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2022.2034257","article-title":"Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1\/PD-L1 blockade immunotherapeutic response in cervical cancer","volume":"11","author":"Wang","year":"2022","journal-title":"Oncoimmunology"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28549","article-title":"Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells","volume":"134","author":"Pahne-Zeppenfeld","year":"2014","journal-title":"Int J Cancer"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1219","article-title":"Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced Malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: integrating single-cell RNA-sequencing and spatial transcriptome","volume":"13","author":"Guo","year":"2023","journal-title":"Clin Transl Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16086","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme","volume":"289","author":"Pallotta","year":"2022","journal-title":"FEBS J"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29389","article-title":"HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells","volume":"137","author":"Demoulin","year":"2015","journal-title":"Int J Cancer"},{"key":"B178","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1038\/s41598-019-49771-0","article-title":"HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1760","article-title":"Tumor immunity and immunotherapy for HPV-related cancers","volume":"11","author":"Shamseddine","year":"2021","journal-title":"Cancer Discov"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0674","article-title":"CheckMate 141: 1-year update and subgroup analysis of nivolumab as first-line therapy in patients with recurrent\/metastatic head and neck cancer","volume":"23","author":"Gillison","year":"2018","journal-title":"Oncologist"},{"key":"B182","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/jco.21.02508","article-title":"Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study","volume":"41","author":"Harrington","year":"2023","journal-title":"J Clin Oncol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0131-9","article-title":"Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012","volume":"119","author":"Mehra","year":"2018","journal-title":"Br J Cancer"},{"key":"B184","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/jcp-2023-209059","article-title":"PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study","volume":"78","author":"Lu","year":"2025","journal-title":"J Clin Pathol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103961","article-title":"Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma","volume":"9","author":"Hong","year":"2024","journal-title":"ESMO Open"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.00914","article-title":"First-line pembrolizumab + chemotherapy versus placebo + chemotherapy for persistent, recurrent, or metastatic cervical cancer: final overall survival results of KEYNOTE-826","volume":"41","author":"Monk","year":"2023","journal-title":"J Clin Oncol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26036","article-title":"Impact of PD-L1 expression and human papillomavirus status in anti-PD1\/PDL1 immunotherapy for head and neck squamous cell carcinoma-systematic review and meta-analysis","volume":"42","author":"Patel","year":"2020","journal-title":"Head Neck"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)01808-7","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"B191","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/s1470-2045(24)00088-3","article-title":"Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial","volume":"25","author":"Oaknin","year":"2024","journal-title":"Lancet Oncol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00780-3","article-title":"Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma","volume":"34","author":"Huang","year":"2021","journal-title":"Mod Pathol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05020-6","article-title":"Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer","volume":"149","author":"Liu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.108","article-title":"Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers","volume":"28","author":"Mezache","year":"2015","journal-title":"Mod Pathol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J Clin Oncol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010092","article-title":"Advancing the fight against cervical cancer: the promise of therapeutic HPV vaccines","volume":"13","author":"Zheng","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1097\/igc.0000000000001235","article-title":"A randomized phase 2 study of ADXS11\u2013001 Listeria monocytogenes-listeriolysin O immunotherapy with or without cisplatin in treatment of advanced cervical cancer","volume":"28","author":"Basu","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004232","article-title":"ISA101 and nivolumab for HPV-16(+) cancer: updated clinical efficacy and immune correlates of response","volume":"10","author":"Sousa","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B199","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-sitc2022.0674","article-title":"674 IMMUNOCERV, an ongoing phase II trial combining PDS0101, an HPV-specific T cell immunotherapy, with chemotherapy and radiation for treatment of locally advanced cervical cancers","volume":"10","author":"Yoshida-Court","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B201","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1200\/jco.2025.43.16_suppl.6037","article-title":"Versatile-002: Overall survival of HPV16-positive recurrent\/metastatic head and neck squamous cell carcinoma patients treated with T cell stimulating immunotherapy PDS0101 and pembrolizumab","volume":"43","author":"Weiss","year":"2025","journal-title":"J Clin Oncol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010827","article-title":"Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study","volume":"13","author":"Hillemanns","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102716","article-title":"GX-188E DNA vaccine plus pembrolizumab in HPV 16- and\/or 18-positive recurrent or advance cervical cancer: a phase 2 trial","volume":"74","author":"Lim","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011633","article-title":"Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"13","author":"Ferris","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovic","year":"2015","journal-title":"J Clin Oncol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2722","article-title":"A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers","volume":"25","author":"Stevanovic","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B207","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1200\/jco.2019.37.15_suppl.2538","article-title":"Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma. Abstract","volume":"37","author":"Jazaeri","year":"2019","journal-title":"J Clin Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01225-1","article-title":"TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers","volume":"27","author":"Nagarsheth","year":"2021","journal-title":"Nat Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.02424","article-title":"T-cell receptor gene therapy for human papillomavirus-associated epithelial cancers: a first-in-human, phase I\/II study","volume":"37","author":"Doran","year":"2019","journal-title":"J Clin Oncol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00371","article-title":"Antigen-specific T-cell activation independently of the MHC: Chimeric antigen receptor-redirected T cells","volume":"4","author":"Chmielewski","year":"2013","journal-title":"Front Immunol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s175516","article-title":"The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma","volume":"11","author":"Dong","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.01.024","article-title":"CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma","volume":"78","author":"Park","year":"2018","journal-title":"Oral Oncol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2733","article-title":"MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma","volume":"9","author":"Mei","year":"2020","journal-title":"Cancer Med"},{"key":"B215","unstructured":"CAR T cell receptor immunotherapy targeting mesothelin for patients with metastatic cancer"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00264-1","article-title":"Anti-mesothelin CAR T cell therapy for Malignant mesothelioma","volume":"9","author":"Castelletti","year":"2021","journal-title":"biomark Res"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.03.019","article-title":"CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma","volume":"49","author":"Nordfors","year":"2013","journal-title":"Eur J Cancer"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-05-1886","article-title":"Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers","volume":"12","author":"Badoual","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.05.640","article-title":"Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease","volume":"45","author":"Distel","year":"2009","journal-title":"Oral Oncol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00262-016-1805-x","article-title":"A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency","volume":"65","author":"Punt","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-9903-2","article-title":"The correlation between tumor-infiltrating Foxp3+ regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers","volume":"29","author":"Sun","year":"2012","journal-title":"Med Oncol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092206","article-title":"Clinical significance of tumor infiltrating T-helper and regulatory cells in Bulgarian cervical cancer patients","volume":"13","author":"Yordanov","year":"2025","journal-title":"Biomedicines"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.7150\/jca.55970","article-title":"Characteristics of infiltrating immune cells and a predictive immune model for cervical cancer","volume":"12","author":"Zou","year":"2021","journal-title":"J Cancer"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju147","article-title":"Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature","volume":"106","author":"Mabuchi","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.7150\/jca.29647","article-title":"Increased circulating GrMyeloid-derived suppressor cells correlated with tumor burden and survival in locally advanced cervical cancer patient","volume":"10","author":"Liang","year":"2019","journal-title":"J Cancer"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.107392","article-title":"Prognostic value of circulating lymphocyte subsets in cervical cancer following postoperative radiotherapy","volume":"22","author":"Wang","year":"2025","journal-title":"Int J Med Sci"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2020.38.15_suppl.e18016","article-title":"Prognostic value of dendritic cells in locally advanced cervical cancer patients","volume":"38","author":"Joseph","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1813400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:36:10Z","timestamp":1777613770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1813400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":227,"alternative-id":["10.3389\/fimmu.2026.1813400"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1813400","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"1813400"}}